Clinical Trials Browser

Withdrawn × INDUSTRY × ceftolozane, tazobactam drug combination × Clear all

NCT05061654 2023-08-14

CEF-10

Phase 4 Withdrawn

Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms, Febrile Neutropenia